Bypass Equipoise Sleeve Trial (BEST)

NCT02767505 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1752

Last updated 2024-02-09

No results posted yet for this study

Summary

This is nationwide registry-based randomised clinical multicenter trial in which patients will be randomised to gastric bypass (RYGB) or sleeve gastrectomy (SG). The co-primary endpoint are weight control over 5 years and the amount of severe adverse events. Additionally the investigators have predefined a number of secondary endpoints, and the trial has a sufficient number of patients to allow comparisons across subgroups.

Conditions

Interventions

OTHER

gastric bypass

Type of surgery: gastric bypass

OTHER

Sleeve gastrectomy

Typ of surgery: sleeve gastrectomy

Sponsors & Collaborators

  • Ersta Hospital, Sweden

    collaborator OTHER
  • Region Örebro County

    collaborator OTHER
  • Kalmar County Hospital

    collaborator OTHER
  • Lindesbergs Hospital

    collaborator UNKNOWN
  • Danderyd Hospital

    collaborator OTHER
  • Skaraborg Hospital

    collaborator OTHER_GOV
  • Sodertalje Hospital

    collaborator OTHER
  • Östra Hospital

    collaborator OTHER
  • Mora Hospital

    collaborator UNKNOWN
  • Torsby Hospital

    collaborator UNKNOWN
  • Stockholm South General Hospital

    collaborator OTHER
  • Gävle Hospital

    collaborator OTHER
  • Uppsala University Hospital

    collaborator OTHER
  • Lycksele Hospital

    collaborator UNKNOWN
  • Falu Hospital

    collaborator OTHER
  • Vrinnevi Hospital, Norrköping

    collaborator UNKNOWN
  • Capio S:t Görans Hospital

    collaborator UNKNOWN
  • Ljungby Hospital

    collaborator UNKNOWN
  • Sykehuset i Vestfold HF

    collaborator OTHER
  • Gjövik Hospital, Norway

    collaborator UNKNOWN
  • GB Obesitas Skane

    collaborator OTHER
  • Göteborg University

    lead OTHER

Principal Investigators

  • Torsten Olbers, MD, PhD · Linköping University, Dept of BKV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2026-12-31
Completion
2031-12-31

Countries

  • Norway
  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02767505 on ClinicalTrials.gov